Transcriptomic scrutiny of PUS1 expression across six prostate cancer in situ foci, including six foci with bone metastases, unveiled heightened PUS1 levels in the latter (Fig. 1E, Table S3). This evidence concerns the gene PUS1 and prostate cancer.